Semaglutide is a GLP-1 receptor agonist with an established track record in both weight management and metabolic health
Product Name: REGENO Cartalax + TB-500 + BPC-157 Strength: 30mg Total Peptide Content Blend Composition: Cartalax 10mg TB-500 10mg BPC-157 10mg Chemical Name: Multi-Peptide Research Blend (Cartalax + TB-500 + BPC-157) Appearance: White to Off-White Lyophilized Powder Classification: Multi-Peptide Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Composite Peptide Research Tissue Organization Studies Extracellular Matrix Research Cartilage Signaling Studies Cellular Migration Research Store lyophilized material refrigerated at 28C for routine storage
Resistant Potato Starch (Solnul), Partially Hydrolyzed Guar Gum (Sunfiber), L
Nuts are a great source of protein, healthy fats, and dietary fibers
Prescription and compounding: legitimate clinical use involves a provider, a prescription, and compounding through a licensed pharmacy
The current fiscal strategy marks a turning point: from expansion to cost containment